Linagliptin

Introduction Linagliptin is an oral hypoglycemic drug belonging to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control. Unlike many other antidiabetic agents, linagliptin has a unique excretion pathway, being mostly eliminated via the enterohepatic system rather than the kidneys, making … Read more